Enovix Corporation (NASDAQ:ENVX – Get Free Report) traded down 8.7% during trading on Tuesday . The stock traded as low as $5.53 and last traded at $5.4150. 908,253 shares traded hands during trading, a decline of 86% from the average session volume of 6,313,135 shares. The stock had previously closed at $5.93.
Analysts Set New Price Targets
A number of equities analysts have issued reports on the company. Canaccord Genuity Group lowered their target price on Enovix from $21.00 to $15.00 and set a “buy” rating for the company in a report on Thursday, February 26th. B. Riley Financial lowered their target price on Enovix from $17.00 to $10.00 and set a “buy” rating for the company in a research report on Monday, March 2nd. Wall Street Zen upgraded Enovix from a “strong sell” rating to a “sell” rating in a research report on Saturday. Weiss Ratings reiterated a “sell (e+)” rating on shares of Enovix in a research report on Friday, April 10th. Finally, Bank of America began coverage on Enovix in a research report on Thursday, March 12th. They issued a “neutral” rating and a $6.00 price objective for the company. Seven analysts have rated the stock with a Buy rating, one has assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat, Enovix currently has an average rating of “Moderate Buy” and a consensus price target of $12.64.
View Our Latest Research Report on ENVX
Enovix Stock Down 6.0%
Enovix (NASDAQ:ENVX – Get Free Report) last announced its earnings results on Wednesday, May 13th. The company reported ($0.14) EPS for the quarter, beating the consensus estimate of ($0.15) by $0.01. Enovix had a negative net margin of 499.64% and a negative return on equity of 64.28%. The company had revenue of $7.60 million during the quarter, compared to the consensus estimate of $6.95 million. During the same quarter in the prior year, the company posted ($0.15) earnings per share. The firm’s revenue for the quarter was up 49.1% on a year-over-year basis. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. Sell-side analysts predict that Enovix Corporation will post -0.81 earnings per share for the current fiscal year.
Institutional Trading of Enovix
A number of institutional investors have recently modified their holdings of ENVX. Caitlin John LLC bought a new position in Enovix in the 3rd quarter worth approximately $27,000. Caitong International Asset Management Co. Ltd bought a new stake in Enovix during the 4th quarter valued at $30,000. Parallel Advisors LLC lifted its position in shares of Enovix by 51.9% during the third quarter. Parallel Advisors LLC now owns 3,926 shares of the company’s stock worth $39,000 after acquiring an additional 1,342 shares in the last quarter. CWM LLC boosted its holdings in shares of Enovix by 95.4% in the fourth quarter. CWM LLC now owns 6,081 shares of the company’s stock worth $44,000 after acquiring an additional 2,969 shares during the period. Finally, Calamos Advisors LLC purchased a new position in shares of Enovix in the first quarter valued at $60,000. 50.92% of the stock is currently owned by hedge funds and other institutional investors.
Enovix Company Profile
Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.
Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.
Further Reading
- Five stocks we like better than Enovix
- Why Home Depot’s Sell-Off Could Become a Huge Opportunity
- The Pentagon’s AI Pivot Supercharges Defense Stocks
- AAPL: Forget the iPhone—Services Will Drive the Next Phase of Growth
- Ackman and Berkshire Are Betting Against Each Other on AI
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.
